Acetyl-d-carnitine

Acetyl-d-carnitine is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 2875 references associated with Acetyl-d-carnitine in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.


Here are additional resources we collected from PubChem and MeSH for Acetyl-d-carnitine

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Acetyl-d-carnitine

MeSH term MeSH ID Detail
Body Weight D001835 333 associated lipids
Alzheimer Disease D000544 76 associated lipids
Amino Acid Metabolism, Inborn Errors D000592 16 associated lipids
Coronary Artery Disease D003324 47 associated lipids
Parkinson Disease D010300 53 associated lipids
Cleft Lip D002971 8 associated lipids
Proteostasis Deficiencies D057165 5 associated lipids
Total 7

All references with Acetyl-d-carnitine

Download all related citations
Per page 10 20 50 100 | Total 877
Authors Title Published Journal PubMed Link
pmid:1892891
pmid:18940920
Hellstrom WJ Medical management of Peyronie's disease. 2009 Jul-Aug J. Androl. pmid:18974422
pmid:18978503
pmid:19015003
pmid:19105586
pmid:19105587
pmid:19111894
pmid:19117335
Zhang Z et al. Acetyl-l-carnitine inhibits TNF-alpha-induced insulin resistance via AMPK pathway in rat skeletal muscle cells. 2009 FEBS Lett. pmid:19121314
pmid:19124012
pmid:19150348
Suchy J et al. Dietary supplementation with a combination of alpha-lipoic acid, acetyl-L-carnitine, glycerophosphocoline, docosahexaenoic acid, and phosphatidylserine reduces oxidative damage to murine brain and improves cognitive performance. 2009 Nutr Res pmid:19185780
Vollaard NB et al. Systematic analysis of adaptations in aerobic capacity and submaximal energy metabolism provides a unique insight into determinants of human aerobic performance. 2009 J. Appl. Physiol. pmid:19196912
pmid:19199082
Valcour V et al. Acetyl-l-carnitine and nucleoside reverse transcriptase inhibitor-associated neuropathy in HIV infection. 2009 HIV Med. pmid:19200173
pmid:19201116
Engle DB et al. Effect of acetyl-l-carnitine on ovarian cancer cells' proliferation, nerve growth factor receptor (Trk-A and p75) expression, and the cytotoxic potential of paclitaxel and carboplatin. 2009 Gynecol. Oncol. pmid:19263582
Musicco C et al. Accumulation of overoxidized Peroxiredoxin III in aged rat liver mitochondria. 2009 Biochim. Biophys. Acta pmid:19272351
pmid:19308954
pmid:19318118
Brass EP et al. Effect of carnitine acetyltransferase inhibition on rat hepatocyte metabolism. 1991 Biochim. Biophys. Acta pmid:1932127
Schroeder MA et al. Real-time assessment of Krebs cycle metabolism using hyperpolarized 13C magnetic resonance spectroscopy. 2009 FASEB J. pmid:19329759
Shenk JC et al. The effect of acetyl-L-carnitine and R-alpha-lipoic acid treatment in ApoE4 mouse as a model of human Alzheimer's disease. 2009 J. Neurol. Sci. pmid:19342064
pmid:19357525
Arafa HM et al. Acetyl-L-carnitine ameliorates caerulein-induced acute pancreatitis in rats. 2009 Basic Clin. Pharmacol. Toxicol. pmid:19371263
Waller AP et al. Oral acetate supplementation after prolonged moderate intensity exercise enhances early muscle glycogen resynthesis in horses. 2009 Exp. Physiol. pmid:19429643
pmid:1944900
pmid:19449442
pmid:19490998
pmid:1952118
pmid:1957705
pmid:19598076
Ruggenenti P et al. Ameliorating hypertension and insulin resistance in subjects at increased cardiovascular risk: effects of acetyl-L-carnitine therapy. 2009 Hypertension pmid:19620516
Whaley-Connell A and Sowers JR Hypertension and insulin resistance. 2009 Hypertension pmid:19635987
Elanchezhian R et al. Evaluation of lenticular antioxidant and redox system components in the lenses of acetyl-L-carnitine treatment in BSO-induced glutathione deprivation. 2009 Mol. Vis. pmid:19649174
pmid:19664977
pmid:19684012
pmid:19697286
pmid:19720082
Rosca MG et al. Mitochondria in the elderly: Is acetylcarnitine a rejuvenator? 2009 Adv. Drug Deliv. Rev. pmid:19720100
Christie LA et al. Short-term supplementation with acetyl-L-carnitine and lipoic acid alters plasma protein carbonyl levels but does not improve cognition in aged beagles. 2009 Exp. Gerontol. pmid:19735717
pmid:1981766
Rueda JR et al. Systematic review of pharmacological treatments in fragile X syndrome. 2009 BMC Neurol pmid:19822023
pmid:19851866
Jensen PR et al. Tissue-specific short chain fatty acid metabolism and slow metabolic recovery after ischemia from hyperpolarized NMR in vivo. 2009 J. Biol. Chem. pmid:19861411
Pourfarzam M and Bartlett K Products and intermediates of the beta-oxidation of [U-14C]hexadecanedionoyl-mono-CoA by rat liver peroxisomes and mitochondria. 1991 Biochem. J. pmid:1989582
pmid:19925851
pmid:19996591
Calabrese V et al. Redox homeostasis and cellular stress response in aging and neurodegeneration. 2010 Methods Mol. Biol. pmid:20013185

Table of Content